You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 255 No. 22, June 13, 1986 TABLE OF CONTENTS
  JAMA
  •  Online Features
  BRIEF REPORT
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (24)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Treatment of Hepatic Metastases in Ocular Melanoma

Embolization of the Hepatic Artery With Polyvinyl Sponge and Cisplatin

C. Humberto Carrasco, MD; Sidney Wallace, MD; Chuslip Charnsangavej, MD; Nicholas E. J. Papadopoulos, MD; Yehuda Z. Patt, MD; Giora M. Mavligit, MD

JAMA. 1986;255(22):3152-3154.


Abstract

Patients with ocular melanoma have a high incidence of hepatic metastases, which primarily determine their length of survival. In an attempt to control the neoplastic disease in the liver, embolization of the hepatic artery with a combination of polyvinyl sponge (Ivalon) and a suspension of cisplatin was performed in two patients with hepatic metastases from ocular melanoma. Dramatic regression of the hepatic metastases, lasting 19 and six months, occurred in these two patients after one or two such treatments. Our preliminary, albeit successful, experience with this therapeutic approach suggests that it may offer relatively prolonged periods of remission and warrants further investigation.

(JAMA 1986;255:3152-3154)



Author Affiliations

From the Departments of Diagnostic Radiology (Drs Carrasco, Wallace, and Charnsangavej), Medical Oncology (Dr Papadopoulos), and Clinical Immunology (Drs Patt and Mavligit), University of Texas M. D. Anderson Hospital and Tumor Institute at Houston.


Footnotes

Reprint requests to Department of Diagnostic Radiology, University of Texas M. D. Anderson Hospital and Tumor Institute, 6723 Bertner, Houston, TX 77030 (Dr Carrasco).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

High-Dose Immunoembolization: Survival Benefit in Patients with Hepatic Metastases from Uveal Melanoma
Yamamoto et al.
Radiology 2009;252:290-298.
ABSTRACT | FULL TEXT  

Intra-arterial Hepatic Chemoembolization (TACE) of Liver Metastases from Ocular Melanoma with Slow-release Irinotecan-eluting Beads. Early Results of a Phase II Clinical Study
FIORENTINI et al.
In Vivo 2009;23:131-137.
ABSTRACT | FULL TEXT  

Immunoembolization of Malignant Liver Tumors, Including Uveal Melanoma, Using Granulocyte-Macrophage Colony-Stimulating Factor
Sato et al.
JCO 2008;26:5436-5442.
ABSTRACT | FULL TEXT  

Regression of Ocular Melanoma Metastatic to the Liver After Hepatic Arterial Chemoembolization With Cisplatin and Polyvinyl Sponge
Mavligit et al.
JAMA 1988;260:974-976.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1986 American Medical Association. All Rights Reserved.